ZNF582 inactivation unleashes HERVH-driven NF-kB signaling in cervical cancer

Technical Summary: ZNF582 Inactivation Unleashes HERVH-Driven NF-κB Signaling in Cervical Cancer

Problem Statement
While persistent high-risk human papillomavirus (HPV) infection is the primary initiator of cervical cancer, the specific host-cell programs that drive the transition from reversible epithelial lesions to invasive disease remain incompletely understood. Although epigenetic markers like ZNF582 are used clinically for triaging HPV-positive women, it is unclear whether their silencing represents a passive consequence of transformation or an active functional vulnerability driving malignancy. Furthermore, the role of endogenous retroviruses (HERVs), which are typically silenced by KRAB zinc finger proteins (KZFPs), in cervical carcinogenesis has not been fully elucidated.

Methodology
The study employed a multi-faceted approach combining pan-cancer bioinformatics, molecular biology, and preclinical modeling:

• Bioinformatics & Pan-Cancer Analysis: The authors utilized The Cancer Genome Atlas (TCGA) and Gene Expression Omnibus (GEO) datasets to correlate the expression of 44 embryogenesis-associated HERVs with 391 human KZFPs across 13 cancer types. They identified ZNF582 as a candidate repressor of HERVH based on negative correlations and motif prediction.
• Genetic Manipulation: CRISPR-Cas9 was used to generate ZNF582 knockout (KO) clones in S12 (HSIL-derived) cells. Gain-of-function (CRISPRa-SAM) and loss-of-function (shRNA) strategies were applied to modulate HERVH expression in S12, SiHa, and CaSki cell lines. Rescue experiments were performed to confirm causality.
• Epigenetic & Binding Assays: Cleavage Under Targets and Tagmentation (CUT&Tag) with anti-FLAG antibodies was used to map ZNF582 binding sites. RNA pulldown coupled with LC-MS/MS, RNA immunoprecipitation (RIP), and RNA fluorescence in situ hybridization (FISH) were employed to identify RNA-protein interactions between HERVH transcripts and NF-κB repressing factor (NKRF).
• Functional Models: Patient-derived normal cervical epithelial organoids were established and subjected to ZNF582 knockdown to assess epithelial homeostasis. Xenograft models using HERVH-activated SiHa cells were utilized to test the efficacy of NF-κB inhibitors (TPCA-1 and JSH-23) in vivo.
• Pharmacological Intervention: NF-κB signaling was inhibited using IKK2 inhibitor TPCA-1 and nuclear translocation inhibitor JSH-23 in cell proliferation assays, organoid cultures, and mouse xenografts.

Key Contributions and Results

1. Identification of the ZNF582–HERVH Axis: Pan-cancer analysis revealed that ZNF582 is significantly downregulated in cervical squamous cell carcinoma (CESC) and inversely correlated with HERVH expression. ZNF582 hypermethylation occurs early in disease progression (from normal to HSIL) and persists through invasive stages, coinciding with HERVH derepression.
2. Direct Repression Mechanism: CUT&Tag assays demonstrated that ZNF582 directly binds to HERVH genomic loci (specifically HERVH-int and LTR7 elements). ZNF582 loss leads to the epigenetic derepression of HERVH, while ZNF582 re-expression restores silencing.
3. HERVH as a Driver of Proliferation: ZNF582 knockout enhanced cell proliferation, a phenotype that was reversed by HERVH knockdown. Conversely, artificial activation of HERVH in low-expression cells increased proliferation, while depleting HERVH in high-expression cells reduced viability. This establishes HERVH as a functional downstream effector of ZNF582 loss.
4. Mechanism of NF-κB Activation: Transcriptomic profiling linked HERVH activation to the upregulation of NF-κB signaling targets (e.g., CCND1, MYC, CXCL8). Mechanistically, HERVH transcripts were found to physically bind the G-patch domain of NKRF (NF-κB repressing factor). This interaction sequesters NKRF, preventing it from binding to the NF-κB subunit p65/RELA. Consequently, the "nuclear brake" on NF-κB target genes is released, amplifying inflammatory and pro-tumorigenic signaling.
5. Organoid and In Vivo Validation: In patient-derived organoids, ZNF582 depletion induced architectural abnormalities, increased proliferation (Ki67), and a shift toward a basal-like state. In mouse xenografts, HERVH-activated tumors grew faster, but this growth was significantly suppressed by NF-κB inhibitors (TPCA-1 and JSH-23), confirming the dependency of this axis on NF-κB signaling.

Significance and Claims
The paper redefines ZNF582 hypermethylation from a mere diagnostic triage marker to a functional epigenetic lesion that initiates a cascade of retroviral derepression. The study proposes a ZNF582–HERVH–NKRF–NF-κB axis where the loss of a KZFP barrier unleashes endogenous retroviral transcripts that act as decoys to hyperactivate inflammatory signaling.

The authors claim that this mechanism explains how HPV-driven transformation is reinforced by host epigenetic erosion. They suggest that local inhibition of NF-κB signaling could serve as a precision interception strategy for ZNF582-silenced, HERVH-high cervical lesions, potentially halting progression before invasive disease sets in. The findings highlight a novel role for nuclear noncoding RNAs in modulating transcriptional repression complexes, distinct from the cytoplasmic viral mimicry pathways previously associated with retroelements.